<!-- google_ad_section_start -->Kidney Disease and Erythrocytosis<!-- google_ad_section_end -->
Health Forums

Go Back   Health Forums > Diseases and Conditions > Diabetes > alt.support.diabetes

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-10-2007, 08:24 AM
ironjustice
Guest
 
Posts: n/a
Default Kidney Disease and Erythrocytosis

I suppose since erythrocytosis is NOW been found to be a .. marker ..
of diabetes .. it may **explain** the high rate of kidney damage found
in those with .. diabetes.

Erythrocytosis causes kidney damage.

<<snip>>
degenerative processes in kidney characterized by increased vascular
permeability, chronic progressive inflammation, hemosiderin
deposition, and general vasodilatation.
<<snip>>

Am J Physiol Regul Integr Comp Physiol
Excessive erythrocytosis in adult mice overexpressing erythropoietin
leads to hepatic, renal, neuronal, and muscular degeneration
Katja Heinicke,1,2 Oliver Baum,3 Omolara O. Ogunshola,1 Johannes Vogel,
1 Thomas Stallmach,4 David P. Wolfer,5 Stephan Keller,1 Klaus Weber,6
Peter D. Wagner,2 Max Gassmann,1 and Valentin Djonov3
1Institute of Veterinary Physiology, Vetsuisse Faculty and Zurich
Center for Integrative Human Physiology (ZIHP), 4Department of
Pathology, and 5Institute of Anatomy, University of Zurich, Zurich;
3Institute of Anatomy, University of Berne, Berne; 6RCC Ltd, Itingen,
Switzerland; and 2Division of Physiology, Department of Medicine,
University of California San Diego, La Jolla, California

Submitted 6 March 2006 ; accepted in final form 8 May 2006


To investigate the consequences of inborn excessive erythrocytosis, we
made use of our transgenic mouse line (tg6) that constitutively
overexpresses erythropoietin (Epo) in a hypoxia-independent manner,
thereby reaching hematocrit levels of up to 0.89. We detected
expression of human Epo in the brain and, to a lesser extent, in the
lung but not in the heart, kidney, or liver of tg6 mice. Although no
acute cardiovascular complications are observed, tg6 animals have a
reduced lifespan. Decreased swim performance was observed in 5-mo-old
tg6 mice. At about 7 mo, several tg6 animals developed spastic
contractions of the hindlimbs followed by paralysis. Morphological
analysis by light and electron microscopy showed degenerative
processes in liver and kidney characterized by increased vascular
permeability, chronic progressive inflammation, hemosiderin
deposition, and general vasodilatation. Moreover, most of the animals
showed severe nerve fiber degeneration of the sciatic nerve, decreased
number of neuromuscular junctions, and degeneration of skeletal muscle
fibers. Most probably, the developing demyelinating neuropathy
resulted in muscular degeneration demonstrated in the extensor
digitorum longus muscle. Taken together, chronically increased Epo
levels inducing excessive erythrocytosis leads to multiple organ
degeneration and reduced life expectancy. This model allows
investigation of the impact of excessive erythrocytosis in individuals
suffering from polycythemia vera, chronic mountain sickness, or in
subjects tempted to abuse Epo by means of gene doping.

chronic mountain sickness; erythropoietin doping; neurodegeneration;
neuromuscular junctions; polycythemia; vascular permeability

--------------------------------------------------------------------------------

Address for reprint requests and other correspondence: V. Djonov,
Institute of Anatomy, Univ. of Berne, Baltzerstrasse 2, CH-3009 Berne
9/Switzerland (e-mail: djonov@ana.unibe.ch)

Am J Physiol Regul Integr Comp Physiol 291: R947-R956, 2006. First
published May 11, 2006; doi:10.1152/ajpregu.00152.2006
--------------------------------------------------------------------------
------

<<snip>>
Antioxidants and iron chelators have also been shown to retard
functional and
morphologic changes observed in progressive kidney disease
<<snip>>

Kidney Int Suppl. 2004 Oct(91):S50-5. Links


Oxidants and iron in chronic kidney disease.


Shah SV.


Division of Nephrology, Department of Medicine, University of Arkansas
for
Medical Sciences, Little Rock, Arkansas.


Oxidants and iron in chronic kidney disease. Oxidants derived either
from
leukocytes in proliferative glomerular nephritis or from resident
glomerular
cells in nonproliferative glomerulonephritis have been shown to have
several
biologic effects relevant to chronic kidney disease. These include:
the ability
of oxidants to damage glomerular basement membrane (GBM) and to
directly induce
proteinuria; effects that would lead to a fall in the glomerular
filtration
rate; and effects that would account for the morphologic changes
observed in
chronic kidney disease. In experimental models the role of oxidants
has been
demonstrated in both proliferative glomerulonephritis (e.g., anti-GBM
antibody
disease) as well as experimental models of minimal change disease and
membranous nephropathy. Oxidants have also been shown to be an
important
mediator of the various pathways that have been implicated in
diabetic
nephropathy. Antioxidants and iron chelators have also been shown to
retard
functional and morphologic changes observed in progressive kidney
disease.
Taken together, these experimental studies suggest an important role
of
oxidants in chronic kidney disease.


PMID: 15461704 [PubMed - in process]


--------------------------------------------------------------------------
------



Who loves ya.
Tom


Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

Reply With Quote
  #2  
Old 09-10-2007, 08:24 AM
kathy
Guest
 
Posts: n/a
Default Re: Kidney Disease and Erythrocytosis

On Sep 9, 11:47 pm, ironjustice <teamtan...@hotmail.com> wrote:
> I suppose since erythrocytosis is NOW been found to be a .. marker ..
> of diabetes .. it may **explain** the high rate of kidney damage found
> in those with .. diabetes.
>
> Erythrocytosis causes kidney damage.
>
> <<snip>>
> degenerative processes in kidney characterized by increased vascular
> permeability, chronic progressive inflammation, hemosiderin
> deposition, and general vasodilatation.
> <<snip>>
>
> Am J Physiol Regul Integr Comp Physiol
> Excessive erythrocytosis in adult mice overexpressing erythropoietin
> leads to hepatic, renal, neuronal, and muscular degeneration
> Katja Heinicke,1,2 Oliver Baum,3 Omolara O. Ogunshola,1 Johannes Vogel,
> 1 Thomas Stallmach,4 David P. Wolfer,5 Stephan Keller,1 Klaus Weber,6
> Peter D. Wagner,2 Max Gassmann,1 and Valentin Djonov3
> 1Institute of Veterinary Physiology, Vetsuisse Faculty and Zurich
> Center for Integrative Human Physiology (ZIHP), 4Department of
> Pathology, and 5Institute of Anatomy, University of Zurich, Zurich;
> 3Institute of Anatomy, University of Berne, Berne; 6RCC Ltd, Itingen,
> Switzerland; and 2Division of Physiology, Department of Medicine,
> University of California San Diego, La Jolla, California
>
> Submitted 6 March 2006 ; accepted in final form 8 May 2006
>
> To investigate the consequences of inborn excessive erythrocytosis, we
> made use of our transgenic mouse line (tg6) that constitutively
> overexpresses erythropoietin (Epo) in a hypoxia-independent manner,
> thereby reaching hematocrit levels of up to 0.89. We detected
> expression of human Epo in the brain and, to a lesser extent, in the
> lung but not in the heart, kidney, or liver of tg6 mice. Although no
> acute cardiovascular complications are observed, tg6 animals have a
> reduced lifespan. Decreased swim performance was observed in 5-mo-old
> tg6 mice. At about 7 mo, several tg6 animals developed spastic
> contractions of the hindlimbs followed by paralysis. Morphological
> analysis by light and electron microscopy showed degenerative
> processes in liver and kidney characterized by increased vascular
> permeability, chronic progressive inflammation, hemosiderin
> deposition, and general vasodilatation. Moreover, most of the animals
> showed severe nerve fiber degeneration of the sciatic nerve, decreased
> number of neuromuscular junctions, and degeneration of skeletal muscle
> fibers. Most probably, the developing demyelinating neuropathy
> resulted in muscular degeneration demonstrated in the extensor
> digitorum longus muscle. Taken together, chronically increased Epo
> levels inducing excessive erythrocytosis leads to multiple organ
> degeneration and reduced life expectancy. This model allows
> investigation of the impact of excessive erythrocytosis in individuals
> suffering from polycythemia vera, chronic mountain sickness, or in
> subjects tempted to abuse Epo by means of gene doping.
>
> chronic mountain sickness; erythropoietin doping; neurodegeneration;
> neuromuscular junctions; polycythemia; vascular permeability
>
> ---------------------------------------------------------------------------*-----
>
> Address for reprint requests and other correspondence: V. Djonov,
> Institute of Anatomy, Univ. of Berne, Baltzerstrasse 2, CH-3009 Berne
> 9/Switzerland (e-mail: djo...@ana.unibe.ch)
>
> Am J Physiol Regul Integr Comp Physiol 291: R947-R956, 2006. First
> published May 11, 2006; doi:10.1152/ajpregu.00152.2006
> --------------------------------------------------------------------------
> ------
>
> <<snip>>
> Antioxidants and iron chelators have also been shown to retard
> functional and
> morphologic changes observed in progressive kidney disease
> <<snip>>
>
> Kidney Int Suppl. 2004 Oct(91):S50-5. Links
>
> Oxidants and iron in chronic kidney disease.
>
> Shah SV.
>
> Division of Nephrology, Department of Medicine, University of Arkansas
> for
> Medical Sciences, Little Rock, Arkansas.
>
> Oxidants and iron in chronic kidney disease. Oxidants derived either
> from
> leukocytes in proliferative glomerular nephritis or from resident
> glomerular
> cells in nonproliferative glomerulonephritis have been shown to have
> several
> biologic effects relevant to chronic kidney disease. These include:
> the ability
> of oxidants to damage glomerular basement membrane (GBM) and to
> directly induce
> proteinuria; effects that would lead to a fall in the glomerular
> filtration
> rate; and effects that would account for the morphologic changes
> observed in
> chronic kidney disease. In experimental models the role of oxidants
> has been
> demonstrated in both proliferative glomerulonephritis (e.g., anti-GBM
> antibody
> disease) as well as experimental models of minimal change disease and
> membranous nephropathy. Oxidants have also been shown to be an
> important
> mediator of the various pathways that have been implicated in
> diabetic
> nephropathy. Antioxidants and iron chelators have also been shown to
> retard
> functional and morphologic changes observed in progressive kidney
> disease.
> Taken together, these experimental studies suggest an important role
> of
> oxidants in chronic kidney disease.
>
> PMID: 15461704 [PubMed - in process]
>
> --------------------------------------------------------------------------
> ------
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://jesuswasavegetarian.7h.com
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk


FACINATING!

Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Diabetes Increase Women's Risk Of Kidney Disease Kurt alt.support.diabetes 8 08-24-2007 04:31 PM
Dietary Intervention For Kidney Disease ironjustice@aol.com alt.support.diabetes 0 07-15-2007 09:31 PM
Urine Test May Predict Diabetic Kidney Disease Kurt alt.support.diabetes 0 03-20-2007 12:41 AM
Kidney Function Jefferson alt.support.diabetes 53 03-07-2007 12:19 PM
Contrast agent danger / kidney disease ironjustice alt.support.diabetes 0 11-20-2006 12:50 PM


All times are GMT. The time now is 11:31 AM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
     
   
 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41